Startup · $8m raised
Every investor coverage indicates participated in a round Kea Therapeutics Ltd raised.
| Investor | Rounds | Invested |
|---|---|---|
| Medical Research Commercialisation Fund (MRCF) | Series A | $8,000,000 |
Companies Kea Therapeutics Ltd acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Kea Therapeutics Ltd. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Brandon Capital's site announces it led $14m for Amaroq Therapeutics, an Otago spinout developing RNA-based cancer treatments — the firm's first deal as a government-backed incubator. The piece also recalls Kea Therapeutics' shutdown.